Prism Clinical Imaging, Inc.

Prism Clinical Imaging, Inc. develops FDA-cleared clinical software tools for advanced medical imaging acquisition, processing, interpretation, and workflow management, with specialization in neurological imaging and brain tumor treatment planning. The company's integrated platform combines anatomical, functional, and physiological images from multiple modalities—including fMRI and DTI/tractography—to support neurosurgical and radiation oncology treatment planning. Prism's software suite comprises four core products: Prism Acquire® (technologist-facing acquisition assistance tool), Prism Process® (core image processing engine), Prism View® (physician interpretation interface for multimodality studies), and Prism Flow® (DICOM communications, storage, and workflow management across physical and cloud-based locations). The company targets neurosurgeons and radiation oncologists treating brain tumors and other neurological disorders, with demonstrated clinical outcomes including procedure time reduction from multi-hour sessions to under two hours and improved surgical safety through advanced pre-treatment mapping. Prism's products are used across distributed clinical locations with integrated access controls and audit logging capabilities. The company participates in major neuroradiology conferences and maintains active engagement with clinical research community partnerships, including collaborations with academic institutions such as Weill Medical College of Cornell University.